(Press-News.org) It is one of the highest-profile cases of scientific fraud in memory: In 2005, South Korean researcher Woo-Suk Hwang and colleagues made international news by claiming that they had produced embryonic stem cells from a cloned human embryo using nuclear transfer. But within a year, the work had been debunked, soon followed by findings of fraud. South Korea put a moratorium on stem-cell research funding. Some scientists abandoned or reduced their work in the field.
But the case is not so simple: By 2007, other stem-cell researchers had found that the debunked research contained a few solid findings amid the false claims. While prior stem-cell findings remained intact, it took time to rebuild support for the field.
Now a study by MIT scholars quantifies the fallout for scientists whose fields suffer high-profile retractions, with a twist: Even valid older research, when cited in a retracted study, loses credibility — especially if the retracted paper involves malfeasance. The fallout from a retraction does not land solely on the scientists who are at fault, but on people in the field more broadly.
As the new paper contends, "scientific misconduct and mistakes, as signaled to the scientific community through retractions, cause a relative decline in the vitality of neighboring intellectual fields." This spillover effect, which includes a 6 percent decline in citations relative to similar, unaffected papers, suggests that scientists would benefit by trying to describe the nature of each retraction in more detail.
"A well-functioning, transparent retraction process is actually part and parcel of the scientific system," says Pierre Azoulay, an economist at the MIT Sloan School of Management, and a co-author of the new study. "We need a system where … journals help the readers spell out the reasons for the retractions, and help the scientific community parse the implications for the forward movement of science."
Identifying the "stigma story"
The paper, "Retractions," is published in the Review of Economics and Statistics, a peer-reviewed economics journal. The authors are Azoulay, the Sloan Distinguished Associate Professor of Management; Fiona Murray, the Alvin J. Siteman Professor of Entrepreneurship, associate dean for innovation at MIT Sloan, and co-director of MIT's Innovation Initiative; Joshua Krieger, a doctoral student at MIT Sloan; and Jeffrey Furman, an economist at Boston University.
Murray and Furman were co-authors of an influential 2012 paper that studied the circumstances in which retractions occur. The new paper, Azoulay notes, is different in that it spotlights "the consequences of retractions, not their antecedents."
The current study focuses on the life sciences. The researchers examined the effects of more than 1,000 retractions of papers published between 1973 and 2007, and retracted by 2009. They also used the PubMed Related Citations Algorithm to help define the research fields relevant to those retracted papers.
Given those definitions of research fields, the researchers then examined the effect of retractions on intellectually related work. One group of 60,000 papers that they examined experienced the 6 percent decline in citation rates after retractions occurred in the same fields. To establish that fact, the researchers compared the citation trajectories of those papers with a control group of 110,000 papers that were published in the same journals. The data and method draw on work Azoulay has compiled and refined while developing numerous other analyses of citation rates in scientific literature.
But within these numbers lie another story: The citation rates for related papers that are still valid drop more precipitously when papers citing them are retracted for reasons of fraud or other misconduct, as opposed to, say, a laboratory mistake.
"Most of the declines in citations and funding we see are driven by fraud cases," Krieger notes. "When an honest mistake happens, the related field doesn't experience this big decline."
Conversely, this means that, given two equally valid sets of past research, legitimate research cited in a paper later retracted for fraud will be more harshly punished.
Further evidence for the "stigma story," as Krieger calls it, is that academic papers and nonacademic papers from firms tend to shun retracted papers at similar rates — but papers from commercial firms do not avoid citing older, still-valid related papers to the same extent as academic researchers. This could mean there is an unfounded flight away from those related papers in academic research.
"Our evidence pointing to the stigma story implies that funding agencies and investigators should be more cautious when deciding to abandon a field after a case of research misconduct," Krieger adds. "We need to be careful in separating what we've learned about the field's scientific status from our strong reactions to the disgrace of misconduct and fraud."
Limits to knowledge
As Azoulay and his colleagues acknowledge, there are limits to their study. It's possible that citations in fields affected by fraud logically should decline more than those marred by honest mistakes, because scientists may rightfully conclude that research areas containing outright fraud are further away from yielding productive results.
"Maybe … fraud retractions and error retractions are different in ways that are correlated for the potential for follow-on research," Azoulay says.
The researchers tried to account for that in their study, by looking at the number of citations garnered by retracted articles prior to the discovery of problems, then correlating that with the impact on related papers. But the numbers do not show an underlying structural reason why retractions for fraud, as opposed to unintentional mistakes, should generate a larger impact on related prior research.
The researchers have a couple of specific policy suggestions to limit unwarranted damage to the accretion of scientific knowledge. For instance, journals that retract articles should offer detailed explanations of why those papers are no longer valid. It would not be hard, they suggest, to develop a basic system of categories of retractions.
"By lumping together honest mistakes and misconduct, we're undermining the smooth functioning of the retraction system," Azoulay says.
INFORMATION:
Written by Peter Dizikes, MIT News Office
Should scientists handle retractions differently?
Study: Retracted papers needlessly stigmatize and jeopardize solid research in related fields
2014-09-04
ELSE PRESS RELEASES FROM THIS DATE:
Students report greater learning gains in traditional science courses
2014-09-04
Students taking traditional, in-class science courses reported higher perceived learning gains than students enrolled in online distance education science courses. Notably, African-American students taking traditional science courses self-reported greater affective and psychomotor learning gains than students taking online science courses.
These are the key findings of a new study co-authored by a Clemson University researcher and published in the most recent issue of Black History Bulletin.
The purpose of the study, funded by a grant from the National Science Foundation ...
Drexel team unveils Dreadnoughtus: A gigantic, exceptionally complete sauropod dinosaur
2014-09-04
This news release is available in Spanish.
PHILADELPHIA (September 4, 2014) – Scientists have discovered and described a new supermassive dinosaur species with the most complete skeleton ever found of its type. At 85 feet (26 m) long and weighing about 65 tons (59,300 kg) in life, Dreadnoughtus schrani is the largest land animal for which a body mass can be accurately calculated. Its skeleton is exceptionally complete, with over 70 percent of the bones, excluding the head, represented. Because all previously discovered supermassive dinosaurs are known only from relatively ...
Phase III FIRST™ (MM-020/IFM 07-01) trial of REVLIMID® (lenalidomide) plus dexamethasone in newly diagnosed multiple myeloma patients who are not candidates for stem cell transplant published in New E
2014-09-04
SUMMIT, N.J. (Sept. 4, 2014) – Celgene Corporation (NASDAQ:CELG) today announced that data from FIRST (MM-020/IFM 07-01)—an open-label phase III randomized study of continuous REVLIMID (lenalidomide) in combination with dexamethasone in patients newly diagnosed with multiple myeloma (NDMM) who are not candidates for stem cell transplant—have been published in the Sept. 4 issue of the New England Journal of Medicine.
Initial findings, including that the trial had met its primary endpoint of progression free survival (PFS), were reported during the plenary session at the ...
Nano-pea pod model widens electronics applications
2014-09-04
New York | Heidelberg, 4 September 2014 -- Periodic chain-like nanostructures are widely used in nanoelectronics. Typically, chain elements include the likes of quantum rings, quantum dots, or quantum graphs. Such a structure enables electrons to move along the chain, in theory, indefinitely. The trouble is that some applications require localised electrons—these are no longer in a continuous energy spectrum but in a discrete energy spectrum, instead. Now, a new study by Russian scientists identifies ways of disturbing the periodicity of a model nanostructure to obtain ...
Speaking of chemistry: Rethinking football head injuries (video)
2014-09-04
WASHINGTON, Sept. 4, 2014 — Football season is here, and along with thousands of lost hours of productivity from fantasy teams, there's a renewed discussion on the impact of head injuries on players. This week's Speaking of Chemistry focuses on a brain disorder called chronic traumatic encephalopathy (CTE), whose symptoms include memory loss, depression and aggressive or violent behavior. Current detection methods can only identify CTE after a patient has died, leaving many NFL players with a diagnosis that came too late. Now doctors are developing a way to spot CTE in ...
Titania-based material holds promise as new insulator for superconductors
2014-09-04
Research from North Carolina State University shows that a type of modified titania, or titanium dioxide, holds promise as an electrical insulator for superconducting magnets, allowing heat to dissipate while preserving the electrical paths along which current flows. Superconducting magnets are being investigated for use in next-generation power generating technologies and medical devices.
Regular conductors conduct electricity, but a small fraction of that energy is lost during transmission. Superconductors can handle much higher currents per square centimeter and lose ...
Normal-weight counselors feel more successful at helping obese patients slim
2014-09-04
A new study by researchers at the Johns Hopkins Bloomberg School of Public Health suggests that normal-weight nutrition and exercise counselors report feeling significantly more successful in getting their obese patients to lose weight than those who are overweight or obese.
A report on the findings, published online Sept. 4 in the journal Obesity, suggests that patients may be more receptive to those who "practice what they preach."
"Our research shows that the personal weight of health professionals matters when assessing their perceived level of success in helping ...
Breast conserving therapy shows survival benefit compared to mastectomy in early-stage patients
2014-09-04
When factoring in what is now known about breast cancer biology and heterogeneity, breast conserving therapy (BCT) may offer a greater survival benefit over mastectomy to women with early stage, hormone-receptor positive disease, according to research from The University of Texas MD Anderson Cancer Center.
The study findings defy the conventional belief that the two treatment interventions offer equal survival, and show the need to revisit some standards of breast cancer practice in the modern era.
The research was presented at the 2014 Breast Cancer Symposium by ...
Disparities persist in early-stage breast cancer treatment, MD Anderson study finds
2014-09-04
Despite its acceptance as standard of care for early stage breast cancer almost 25 years ago, barriers still exist that preclude patients from receiving breast conserving therapy (BCT), with some still opting for a mastectomy, according to research from The University of Texas MD Anderson Cancer Center.
The study, to be presented at the 2014 Breast Cancer Symposium, finds that those barriers that still exist are socio-economic, rather than medically-influenced. Meeghan Lautner, M.D., formerly a fellow at MD Anderson, now at The University of Texas San Antonio, will present ...
AIBS analysis of peer review offers insights into research productivity
2014-09-04
RESTON, VA – In a paper published today in the journal PLOS One, investigators with the American Institute of Biological Sciences report findings from an analysis of the research output from a series of biomedical research grants funded after undergoing a scientific peer review process. The results, reported in 'The Validation of Peer Review Through Research Impact Measures and the Implications for Funding Strategies,' offer insights for future research on peer review and potential models for increasing research productivity.
"Some form of peer review is used at the ...
LAST 30 PRESS RELEASES:
New route to ‘quantum spin liquid’ materials discovered for first time
Chang’e-6 basalts offer insights on lunar farside volcanism
Chang’e-6 lunar samples reveal 2.83-billion-year-old basalt with depleted mantle source
Zinc deficiency promotes Acinetobacter lung infection: study
How optogenetics can put the brakes on epilepsy seizures
Children exposed to antiseizure meds during pregnancy face neurodevelopmental risks, Drexel study finds
Adding immunotherapy to neoadjuvant chemoradiation may improve outcomes in esophageal cancer
Scientists transform blood into regenerative materials, paving the way for personalized, blood-based, 3D-printed implants
Maarja Öpik to take up the position of New Phytologist Editor-in-Chief from January 2025
Mountain lions coexist with outdoor recreationists by taking the night shift
Students who use dating apps take more risks with their sexual health
Breakthrough idea for CCU technology commercialization from 'carbon cycle of the earth'
Keck Hospital of USC earns an ‘A’ Hospital Safety Grade from The Leapfrog Group
Depression research pioneer Dr. Philip Gold maps disease's full-body impact
Rapid growth of global wildland-urban interface associated with wildfire risk, study shows
Generation of rat offspring from ovarian oocytes by Cross-species transplantation
Duke-NUS scientists develop novel plug-and-play test to evaluate T cell immunotherapy effectiveness
Compound metalens achieves distortion-free imaging with wide field of view
Age on the molecular level: showing changes through proteins
Label distribution similarity-based noise correction for crowdsourcing
The Lancet: Without immediate action nearly 260 million people in the USA predicted to have overweight or obesity by 2050
Diabetes medication may be effective in helping people drink less alcohol
US over 40s could live extra 5 years if they were all as active as top 25% of population
Limit hospital emissions by using short AI prompts - study
UT Health San Antonio ranks at the top 5% globally among universities for clinical medicine research
Fayetteville police positive about partnership with social workers
Optical biosensor rapidly detects monkeypox virus
New drug targets for Alzheimer’s identified from cerebrospinal fluid
Neuro-oncology experts reveal how to use AI to improve brain cancer diagnosis, monitoring, treatment
Argonne to explore novel ways to fight cancer and transform vaccine discovery with over $21 million from ARPA-H
[Press-News.org] Should scientists handle retractions differently?Study: Retracted papers needlessly stigmatize and jeopardize solid research in related fields